San Francisco funding news: Health care and commerce top recent local investments

Photo: Skyroam/Facebook

San Francisco-based biotechnology company Kindred Biosciences has secured $50 million in post IPO debt funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced on Oct. 2 and financed by Solar Capital Partners.

According to its Crunchbase profile, "Kindred Biosciences Inc., a veterinary biotechnology company, focuses on developing therapies for dogs, cats and horses. It develops canine, feline and equine antibodies for the treatment of diseases in companion animals."

The seven-year-old company has raised three previous funding rounds, including a $5.2 million post IPO equity round in 2017.

The round brings total funding raised by San Francisco companies in health care over the past month to $363 million, an increase of $206 million from the month before. The local health care industry has seen 210 funding rounds over the past year, capturing a total of $4.8 billion in venture funding.

In other local funding news, shipping company Darkstore announced a $21 million Series B funding round on Sept. 19, financed by EQT Ventures.

According to Crunchbase, "Darkstore is an accessible same-day delivery option on every website that enables access to better products to make both people’s lives and the world a better place. All of their fulfillment locations support on-demand, same-day and two-day deliveries. Orders are automatically routed to the fulfillment location that provides the lowest rate for the delivery."

Founded in 2017, the company has raised four previous rounds, including a $7.5 million Series A round earlier this year.

Meanwhile, banking company Mercury raised $20 million in Series A funding, announced on Sept. 26. The round's investors were led by CRV.

From the company's Crunchbase profile: "Mercury is a bank for startups, engineered in Silicon Valley for tech companies."

Mercury last raised $6 million in seed funding earlier this year.

Also of note, wireless company Skyroam raised $20 million in Series C funding, announced on September 26 and led by Mesh Ventures.

From Crunchbase: "Skyroam was founded in Silicon Valley by technology veterans who have identified a common point of pain among fellow business travelers: Getting a fast, reliable mobile internet connection while on the road is a challenge. And when returning home, the traveler invariably receives a shockingly high roaming bill. This problem is becoming more acute as data consumption skyrockets, driven by smartphones, tablets, netbooks and even wearables."

The company previously raised $20 million in Series C funding in 2018.

Rounding out the city's recent top local funding events, life science company Aktana raised $20 million in debt financing funding, announced on Sept. 25 and financed by CIBC Innovation Banking.

From Crunchbase: "Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments and drive channel productivity and results."

The company previously raised $21 million in Series C funding in 2018.

This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.